HBV Forum 16 Meeting was held on Tuesday, May 26, 2026 in Barcelona, Spain

Materials

Agenda
Meeting Summary
Participant List

Introductory Remarks and Program Overview

Welcome, Forum Updates, Program Overview and Acknowledgements
*Ekene Osakwe, Forum for Collaborative Research

Steering Committee Co-Chair Welcoming Remarks
Veronica Miller, Forum for Collaborative Research
Carey Hwang, IntegerBio
Norah Terrault, Keck School of Medicine of USC

Session I: Updates

Rapid Fire Industry Updates
Sue Currie, Viron Therapeutics
*Jerry Wallweber, Labcorp-Monogram Biosciences
Emily Harrison, Precision BioSciences
Tracy McGregor, nChroma Bio
Todd Correll, Vir Biotechnology
Kendra Congdon, Tune Therapeutics
Christian Voitenleitner, Roche Diagnostics International

European Medicines Agency HBV Guideline Review Update
Carey Hwang, IntegerBio

Feedback from the World Hepatitis Summit, Bangkok
Cary James, World Hepatitis Alliance

Standardizing HBV Nomenclature, Update from Societies
Norah Terrault, Keck School of Medicine of USC

Open Discussion
All Meeting Participants

Session II: HBV and Metabolic Associated Steatotic Liver Disease

HBV/MASLD Draft Paper: Emerging Issues & Recommendations from the Working Group
Milan Sonneveld, Erasmus University Medical Center

Open Discussion
All Meeting Participants

Session III: Hepatitis Delta Therapeutics: Clinical Trial Endpoints

HDV Working Group: Summary of Key Discussions in Endpoints Design for HDV Clinical Trials
Pietro Lampertico, University of Milan

Panel/Open Discussion
Carey Hwang, Integer Bio
Cary James, World Hepatitis Alliance
*Yasmin Ibrahim, Hepatitis B Foundation
All Meeting Participants

Session IV: Advancing HBV Treatment Access in Sub-Saharan Africa

2for1: Integrate to Eliminate Project Overview
Philippa Easterbrook, Imperial College London

Panel/Open Discussion: Long acting HIV Injectables & HBV
Norah Terrault, Keck School of Medicine of USC
Bob Gish, Robert G Gish Consultants LLC
All Meeting Participants

Session V: Hepatocellular Carcinoma: Gaps and Opportunities for Early Detection

Key Takeaways from the Hep B Foundation Workshop on Gaps and Opportunities to Improve Early HCC Detection
*Brian McMahon, Alaska Native Tribal Health Consortium

Perspectives from Asia
Lung-Yi Loey Mak, The University of Hong Kong

Perspectives from Africa
Asgeir Johannessen, Center for Global Health, University of Oslo

Perspectives from the Americas
*George loannou, University of Washington/VA  Puget Sound Healthcare System

Open Discussion
All Meeting Participants

* Remote Participation